The Journal of the Korean dental association (대한치과의사협회지)

The Korean Dental Association (대한치과의사협회)
권호 표지

Considerations during dental implant treatment for patients under bisphosphonate therapy

Bisphosphonate를 복용하는 환자에게 임프란트 치료시 고려사항

  • Park, Won-Se (Department of advanced general dentistry, College of dentistry, Yonsei University) ;
  • Chung, Won-Yoon (Department of oral biology, College of dentistry, Yonsei University) ;
  • Kim, Hyung-Jun (Department of oral and maxillofacial sugery, College of dentistry, Yonsei University) ;
  • Kim, Kee-Deog (Department of advanced general dentistry, College of dentistry, Yonsei University)
  • 박원서 (연세대학교 치과대학 통합진료학과) ;
  • 정원윤 (연세대학교 치과대학 구강생물학교실) ;
  • 김형준 (연세대학교 치과대학 구강악안면외과학교실) ;
  • 김기덕 (연세대학교 치과대학 통합진료학과)
  • Published : 2011.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Bisphosphonate inhibits the function of osteoclast, so they are widely used for multiple myeloma, Paget's disease, metastatic malignant bone disease, and severe osteoporosis. This drug is very effective for preventing severe complication of osteoporosis, some unpredictable complication occurred such as esophageal malignancy, atypical fracture of femur, and osteonecrosis of the jaw. Bisphosphonate related osteonecrosis of the jaw (BRONJ) is closely related with invasive, open bone surgery like tooth extraction. BRONJ associated with dental implant is rare, however, as the use of bisphosphonate increase, BRONJ cases with dental implant are increasing. In this article, we will describe the considerations during dental implant treatment for patient under bisphosphonate therapy.

Keywords

References

  1. Patel V, McLeod NM, Rogers SN, Brennan PA. Bisphosphonate osteonecrosis of the jaw-a literature review of UK policies versus International policies on bisphosphonates, risk factors and prevention. Br J Oral Maxillofac Surg 2011 ;49(4) :251-257. https://doi.org/10.1016/j.bjoms.2010.05.007
  2. oneda T, Hagino H, Sugimoto T, et at Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodobntology, Japanese Society for Oral and Maxillofacial Radiology, and spanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 2010;28(4):365-383. https://doi.org/10.1007/s00774-010-0162-7
  3. Ruggiero SL, Dodson TB, Assael LA, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg 2009;67(5 Suppl):2-12.
  4. Ruggiero SL, Dodson TB, Assael LA, et at American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J 2009;35(3):119-130. https://doi.org/10.1111/j.1747-4477.2009.00213.x
  5. Filleul O, Crompot E, Saussez S. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 2010;133(8):1117-1124.
  6. Marx RE, Cillo E, Jr., Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxiliofac Surg 2007;65(12):2397-2410. https://doi.org/10.1016/j.joms.2007.08.003
  7. Ruggiero SL, Drew SJ. Osteonecrosis of the jaws and blsphosphonate therapy. J Dent Res 2007:86(11):1013-1021. https://doi.org/10.1177/154405910708601101
  8. Markiewicz MR, Margarone JE, 3rd, Campbell JH, Aguirre A. Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge. J. Am Dent Assoc 2005;133(12):1669-1674.
  9. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avasa.ttar necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61(9):1115-1117. https://doi.org/10.1016/S0278-2391(03)00720-1
  10. Schwartz JE. Ask us: Some drugs affect tooth movement. Am J Orthod Dentofacial Orthop 2005; 127(6) :644. https://doi.org/10.1016/j.ajodo.2005.04.028
  11. Zahrowski JJ. Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis. Am J Orthod Dentofaclal Orthop 2009; 135(3) :331-374.
  12. Rinchuse DJ. Sasovicka MF, Robison JM, Pendleton R. Orthodontic treatment of patients using bisphosphonates: a report of 2 cases. Am J Orthod Dentofacial Orthop 2007; 131(3) :321-326. https://doi.org/10.1016/j.ajodo.2006.11.002
  13. Zahrowski JJ. Bisphosphonate treatment: an orthodontic concern calling for a proactive approach. Am J Orthod Dentofacial Orthop 2007;131(3):311-320. https://doi.org/10.1016/j.ajodo.2006.09.035
  14. Taguchi A. Triage screening for osteoporosis in dental clinics using panoramic radiographs. Oral Dis 2010; 16(4) :316-327. https://doi.org/10.1111/j.1601-0825.2009.01615.x
  15. Taguchi A. Asano A. Ohtsuka M, et al. Observer performance in diagnosing osteoporosis by dental panoramic radiographs: results from the osteoporosis screening project in dentistry (OSPD). Bone 2008; 43(1) : 209-213. https://doi.org/10.1016/j.bone.2008.03.014
  16. Bell BM, Bell RE. Oral bisphosphonates and dental implants: a retrospective study. J Oral Maxillofac Surg 2008;66(5): 1022-1024. https://doi.org/10.1016/j.joms.2007.12.040
  17. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg 2008;66(2) :223-230. https://doi.org/10.1016/j.joms.2007.09.019
  18. Javed F, Almas K. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol 2010;81(4):479-484. https://doi.org/10.1902/jop.2009.090587
  19. Shirota T, Nakamura A, Matsui Y, et al. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case. Clin Oral Implants Res 2009;20(12):1402-1408. https://doi.org/10.1111/j.1600-0501.2009.01801.x
  20. Bedogni A, Bettini G, Totola A, et al. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review. J Oral Maxillofac Surg 2010;68(7):1662-1666. https://doi.org/10.1016/j.joms.2010.02.037
  21. Goss A. Bartold M, Sambrook P, Hawker P. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series. J Oral Maxillofac Surg 2010;68(2) :337-343. https://doi.org/10.1016/j.joms.2009.09.037
  22. Lazarovici TS, Yahalom R, Taicher S, et al. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg 2010;68(4) :790-796. https://doi.org/10.1016/j.joms.2009.09.017
  23. Martin DC, O'Ryan FS, Indresano AT, et al. Characteristics of implant failures in patients with a history of oral bisphosphonate therapy. J Oral Maxillofac Surg 2010;68(3) :508-514. https://doi.org/10.1016/j.joms.2009.09.055